Benzinga's Top Initiations

Analysts at Scotia Howard Weil initiated coverage on Enterprise Products Partners L.P. EPD with a Sector Outperform rating. The target price for Enterprise Products Partners is set to $31. Enterprise Products Partners shares closed at $26.22 on Tuesday. Canaccord Genuity initiated coverage on Evolent Health Inc EVH with a Buy rating. Evolent Health shares closed at $12.03 on Tuesday. Analysts at Atlantic Equities initiated coverage of Colgate-Palmolive Company CL with a Overweight rating. Colgate-Palmolive shares closed at $65.00 on Tuesday. Analysts at JP Morgan initiated coverage on Impax Laboratories Inc IPXL with a Neutral rating. The target price for Impax Laboratories is set to $47. Impax Laboratories shares closed at $42.65 on Tuesday. Analysts at Wells Fargo initiated coverage on New Jersey Resources Corp NJR with a Market Perform rating. New Jersey Resources shares closed at $34.09 on Tuesday. JMP Securities initiated coverage on Green Brick Partners Inc GRBK with a Market Perform rating. Green Brick Partners shares closed at $6.99 on Tuesday. H.C. Wainwright initiated coverage of Codexis, Inc. CDXS with a Buy rating. The target price for Codexis is set to $6. Codexis shares closed at $4.23 on Tuesday. JP Morgan initiated coverage on Arista Networks Inc ANET with a Neutral rating. Arista Networks shares closed at $78.22 on Tuesday. Analysts at Barclays initiated initiated coverage on Diplomat Pharmacy Inc DPLO with a Overweight rating. The target price for Diplomat Pharmacy is set to $41. Diplomat Pharmacy shares closed at $35.00 on Tuesday. Analysts at Janney Capital initiated coverage on Cerulean Pharma Inc CERU with a Buy rating. Cerulean Pharma shares closed at $3.04 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!